thrive semaglutide GLP-1 Medical Weight Loss Thrive Wellness Clinic (@thrivewellness18) ·

National Library of Medicine , "FDA Approves Ozempic (Semaglutide) as the Only GLP-1 RA to Reduce the Risk of Worsening Kidney Disease and Cardiovascular Death in Adults with Type 2 Diabetes and Chronic Kidney Disease." PR Newswire , "FDA Approves Wegovy (Semaglutide) for Adults with Obesity." Drugs.com , 2021, Fonseca, Vivian A., et al

The Bottom Line GLP-1 medications are important treatments for many patients, but newer research has raised questions about a possible association between semaglutide and NAION

Hepatic peroxisome proliferator-activated receptor gamma coactivator 1beta drives mitochondrial and anabolic signatures that contribute to hepatocellular carcinoma progression in mice

But are these injections truly safe and effective